Patent holdings for IPC class A61K 31/451

Total number of patents in this class: 875

10-year publication summary

78
63
71
81
87
72
93
86
66
13
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Prilenia Neurotherapeutics Ltd.
83
61
ChemoCentryx, Inc.
400
32
Takeda Pharmaceutical Company Limited
2961
17
Pacira Pharmaceuticals, Inc.
85
14
H. Lundbeck A/S
1252
14
Bristol-myers Squibb Company
5080
12
The University of Chicago
1282
12
AstraZeneca AB
3042
11
Amgen Inc.
3779
11
Janssen Pharmaceutica N.V.
3839
10
Heptares Therapeutics Limited
225
10
Novartis AG
11238
9
Teoxane
40
9
Teva Pharmaceuticals USA, Inc.
1040
9
Toray Industries, Inc.
6652
8
Purdue Pharma L.P.
519
8
Teva Pharmaceuticals International GmbH
355
8
The Trustees of the University of Pennsylvania
4122
7
Daiichi Sankyo Company, Limited
1829
7
The Regents of the University of California
18943
6
Other owners 600